Mittal Khyati, Katare Deepshikha Pande
Proteomics and Translational Research Lab, Centre for Medical Biotechnology, Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India.
Proteomics and Translational Research Lab, Centre for Medical Biotechnology, Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India.
Diabetes Metab Syndr. 2016 Apr-Jun;10(2 Suppl 1):S144-9. doi: 10.1016/j.dsx.2016.01.021. Epub 2016 Feb 11.
Epidemiological studies have proved that, there are pathophysiological connections between Type 2 Diabetes Mellitus (T2DM) and Alzheimer's disease (AD). Diabetic patients have higher incidences of cognitive impairment and hence they are more at the risk of developing AD. Some of the recent evidences have majorly stated the effects of insulin resistance in the disturbance of various biological processes and signaling pathways. Both hyperglycemia and hypoglycemic conditions contributes in dysfunctioning of cognitive abilities and functions. The present review summarizes the evidences which establish the possible links between the two pathologies on the account of molecular, biochemical and at histopathological level. The information regarding their interactions was collected from different databases and journals. The gathered information will clearly establish the link among the two pathologies and will be helpful in future for the development of drugs for Type 3 Diabetes.
流行病学研究已经证明,2型糖尿病(T2DM)与阿尔茨海默病(AD)之间存在病理生理联系。糖尿病患者认知障碍的发生率较高,因此他们患AD的风险更大。最近的一些证据主要阐述了胰岛素抵抗在各种生物过程和信号通路紊乱中的作用。高血糖和低血糖状态都会导致认知能力和功能障碍。本综述总结了在分子、生化和组织病理学水平上建立这两种疾病之间可能联系的证据。关于它们相互作用的信息是从不同的数据库和期刊中收集的。收集到的信息将清楚地建立这两种疾病之间的联系,并将有助于未来开发治疗3型糖尿病的药物。